COPD exacerbations in the phase 3 revefenacin clinical trial program

2018 ◽  
Author(s):  
James F. Donohue ◽  
Sanjay Sethi ◽  
Craig N. Barnes ◽  
Edmund J. Moran ◽  
Srikanth Pendyala ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 3 ◽  
Copd Exacerbations ◽  
Clinical Trial Program

scholarly journals Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)

2018 ◽  
Vol 124 (1) ◽  
pp. 27-38 ◽  
Author(s):  
Janet Thomas ◽  
Harvey Levy ◽  
Stephen Amato ◽  
Jerry Vockley ◽  
Roberto Zori ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 3 ◽  
Clinical Trial Program

scholarly journals Efficacy of Ceftazidime-Avibactam against Multi-Drug Resistant Enterobacteriaceae and Pseudomonas aeruginosa from the Phase 3 Clinical Trial Program

2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Gregory G. Stone ◽  
Leanne Gasink ◽  
Paul Newell ◽  
Helen Broadhurst ◽  
Angela Wardman ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Pseudomonas Aeruginosa ◽  
Drug Resistant ◽  
Phase 3 ◽  
Clinical Trial Program

scholarly journals PF703 LONG-TERM FOSTAMATINIB TREATMENT OF ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP) DURING THE PHASE 3 CLINICAL TRIAL PROGRAM

HemaSphere ◽  
2019 ◽  
Vol 3 (S1) ◽  
pp. 306
Author(s):  
J. Bussel ◽  
D. Arnold ◽  
R. Boccia ◽  
M. Boxer ◽  
N. Cooper ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Immune Thrombocytopenia ◽  
Phase 3 ◽  
Clinical Trial Program

scholarly journals Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program

2019 ◽  
Vol 94 (5) ◽  
pp. 546-553 ◽  
Author(s):  
James B. Bussel ◽  
Donald M. Arnold ◽  
Michael A. Boxer ◽  
Nichola Cooper ◽  
Jiri Mayer ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Immune Thrombocytopenia ◽  
Phase 3 ◽  
Clinical Trial Program
Sign in / Sign up

Export Citation Format

Share Document